Recruiting Type 1 Diabetes Studies in Columbus
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insul...
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....
About Type 1 Diabetes Clinical Trials in Columbus
Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells in the pancreas. It typically develops in childhood or young adulthood and requires lifelong insulin therapy. Research is exploring artificial pancreas systems, immunotherapy, and beta cell replacement.
There are currently 2 type 1 diabetes clinical trials recruiting participants in Columbus, OH. These studies are seeking a combined 873 participants. Research is being sponsored by Sanofi, vTv Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Type 1 Diabetes Clinical Trials in Columbus — FAQ
Are there type 1 diabetes clinical trials in Columbus?
Yes, there are 2 type 1 diabetes clinical trials currently recruiting in Columbus, OH. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Columbus?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you about next steps.
Are clinical trials in Columbus free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbus studies also compensate for your time and travel.
What type 1 diabetes treatments are being tested?
The 2 active trials in Columbus are testing new therapies including novel drugs, biologics, and treatment approaches for type 1 diabetes.
Data updated March 2, 2026 from ClinicalTrials.gov